Status:
UNKNOWN
Effect of RIPC on the Prevention of POD in Patients Undergoing Cardiac Surgery
Lead Sponsor:
Shanghai Zhongshan Hospital
Conditions:
Postoperative Delirium
Cardiac Surgery
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Postoperative delirium (POD) is one of the most frequent neurological complications in elderly patients and is closely associated with longer ICU stay and hospitalization, deterioration of long-term n...
Eligibility Criteria
Inclusion
- patients undergoing elective cardiac surgery;
- age ≥ 18 yr;
- any sex;
- American Society of Anesthesiologists (ASA) class ≥II class;
- New York Heart Association (NYHA) ≥II class.
Exclusion
- emergency surgery;
- a history of cardiovascular surgery;
- peripheral vascular disease affecting the upper limbs;
- acute myocardial infarction (MI) up to 14 days before surgery;
- a history of severe injuries and operations within 3 months before cardiac surgery;
- a history of cancer and chronic autoimmune diseases.
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
216 Patients enrolled
Trial Details
Trial ID
NCT05434455
Start Date
July 1 2022
End Date
December 31 2023
Last Update
June 30 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.